Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Gliosarcoma 31Glioblastoma 30Sarcoma 22Rhabdomyosarcoma 8Brain Neoplasms 7Astrocytoma 7Central Nervous System Neoplasms 6Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Bone Neoplasms 4Sarcoma, Synovial 3Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Osteosarcoma 3Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Rhabdomyosarcoma, Alveolar 2Prostatic Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Neoplasms 2Medulloblastoma 2Dermatofibrosarcoma 2Carcinoma, Merkel Cell 2Vulvar Neoplasms 1

Interventions

repotrectinib 1pembrolizumab 1pamiparib 1interferon gamma-1b 1capmatinib 1Trabectedin 1Temozolomide 1Radiation 1Oncolytic Virotherapy 1Irinotecan 1Interferon-gamma 1Immunotherapy 1FANG vaccine 1Doxorubicin 1Dexamethasone 1Cyclophosphamide 1ARQ531 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasms by Histologic Type × Radiation × Sarcoma × Clear all
NCT03150862 2025-02-04

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

BeiGene

Phase 1/2 Completed
116 enrolled 31 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡